Soto Beauregard C, Murcia Zorita J, López Gutiérrez J C, Salas S, Quero J, Lassaletta Garbayo L, Tovar Larrucea J A
Departamento de Cirugía Pediátrica y Servicio de Neonatología. Hospital Infantil La Paz, Madrid.
An Esp Pediatr. 1996 Jun;44(6):568-72.
Some neonates with congenital diaphragmatic hernia (CDH) and persistent pulmonary hypertension are not adequately oxygenated with conventional treatment. The extracorporeal membrane oxygenation (ECMO) has been successful in some of them as an alternative in their management.
We studied the charts of 47 neonates with CDH, symptomatic within 24 hours of birth, treated in our institution during the last seven years (1987-1994). In all of them, conventional ventilation and hemodynamic support was used. In 12 patients high frequency ventilation (HFV) was used and two survived. In all patients we analyzed the following ventilatory and gasometric parameters: Oxygenation index (OI), ventilatory index (VI)* and postductal PCO2. In 15 neonates who did not survive, a necropsy was performed and a morphometric parameter, pulmonary index (PI)*** was studied.
The overall survival was 60%. VI and OI showed significant differences (p < 0.001) between survivors and non-survivors with values of 460.9 +/- 303 vs 1532 +/- 500.6, respectively for VI and 10.3 +/- 5.7 vs 46.2 +/- 37.8, respectively for IO. There were no significant differences in postductal PCO2. Mean PI in the 15 non-survivors was 0.0072 +/- 0.002 (normal > 0.015). Regression coefficients of PI with OI or VI were not significant. Neonates with VI < 1000 and OI < 40 survived. All patients with VI > 1000 and OI > 40 died. Some babies with VI > 1000 and OI < 40 (21.6%) survived.
In our experience, the use of HFV did not improve the prognosis of these patients, but we believe that the use of ECMO in those patients with VI > 1000, and overall, patients with VI > 1000 and OI < 40 would improve the survival rates of this congenital malformation. *QI = FiO2 x MAP/PO2 postductal x 100. (MAP = Median airway pressure). **VI = VR x MAP (VR = Ventilatory rate). ***PI = Pulmonary weight/Body weight.
一些患有先天性膈疝(CDH)和持续性肺动脉高压的新生儿采用传统治疗方法时氧合不充分。体外膜肺氧合(ECMO)作为一种替代治疗手段,已在部分此类患儿中取得成功。
我们研究了过去七年(1987 - 1994年)在我院接受治疗的47例出生后24小时内出现症状的CDH新生儿的病历。所有患儿均采用了传统通气和血流动力学支持治疗。其中12例患儿使用了高频通气(HFV),2例存活。我们分析了所有患儿的以下通气和气体测量参数:氧合指数(OI)、通气指数(VI)和导管后PCO2。对15例死亡新生儿进行了尸检,并研究了一个形态学参数——肺指数(PI)。
总体存活率为60%。存活者与非存活者之间的VI和OI存在显著差异(p < 0.001),VI值分别为460.9±303和1532±500.6,OI值分别为10.3±5.7和46.2±37.8。导管后PCO2无显著差异。15例非存活者的平均PI为0.0072±0.002(正常>0.015)。PI与OI或VI的回归系数无显著意义。VI<1000且OI<40的新生儿存活。所有VI>1000且OI>40的患儿均死亡。一些VI>1000且OI<40的患儿(21.6%)存活。
根据我们的经验,使用HFV并未改善这些患儿的预后,但我们认为,对于VI>1000的患儿,总体而言,对于VI>1000且OI<40的患儿使用ECMO将提高这种先天性畸形的存活率。*QI = FiO2×MAP/导管后PO2×100。(MAP = 平均气道压)**VI = VR×MAP(VR = 通气频率)***PI = 肺重量/体重